Abstract

1Journal of the American Society of Nephrology, Bernard, Maine 2Department of Quantitative Health Sciences, Lerner Research Institute and Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 3Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio Correspondence: Dr. Josephine Briggs, PO Box 125 Bernard, ME 04612. Email: [email protected] See related article, “Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes,” on pages 385–393.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call